X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ALKEM LABORATORIES - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD ALKEM LABORATORIES MERCK LTD/
ALKEM LABORATORIES
 
P/E (TTM) x 26.5 - - View Chart
P/BV x 3.0 6.0 49.6% View Chart
Dividend Yield % 1.0 0.7 131.6%  

Financials

 MERCK LTD   ALKEM LABORATORIES
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ALKEM LABORATORIES
Mar-16
MERCK LTD/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0601,589 66.7%   
Low Rs6231,232 50.6%   
Sales per share (Unadj.) Rs632.4417.5 151.5%  
Earnings per share (Unadj.) Rs45.756.3 81.2%  
Cash flow per share (Unadj.) Rs62.364.7 96.3%  
Dividends per share (Unadj.) Rs11.0012.70 86.6%  
Dividend yield (eoy) %1.30.9 145.2%  
Book value per share (Unadj.) Rs388.8292.9 132.7%  
Shares outstanding (eoy) m16.60119.57 13.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.4 39.4%   
Avg P/E ratio x18.425.1 73.5%  
P/CF ratio (eoy) x13.521.8 62.0%  
Price / Book Value ratio x2.24.8 44.9%  
Dividend payout %24.122.6 106.7%   
Avg Mkt Cap Rs m13,969168,653 8.3%   
No. of employees `0001.6NA-   
Total wages/salary Rs m1,4879,171 16.2%   
Avg. sales/employee Rs Th6,631.9NM-  
Avg. wages/employee Rs Th939.2NM-  
Avg. net profit/employee Rs Th479.4NM-  
INCOME DATA
Net Sales Rs m10,49849,915 21.0%  
Other income Rs m2421,645 14.7%   
Total revenues Rs m10,74151,561 20.8%   
Gross profit Rs m1,1358,482 13.4%  
Depreciation Rs m2761,006 27.4%   
Interest Rs m0671 0.0%   
Profit before tax Rs m1,1028,451 13.0%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,606 21.4%   
Profit after tax Rs m7596,731 11.3%  
Gross profit margin %10.817.0 63.6%  
Effective tax rate %31.119.0 163.9%   
Net profit margin %7.213.5 53.6%  
BALANCE SHEET DATA
Current assets Rs m6,41027,062 23.7%   
Current liabilities Rs m8,82815,324 57.6%   
Net working cap to sales %-23.023.5 -98.0%  
Current ratio x0.71.8 41.1%  
Inventory Days Days5867 86.7%  
Debtors Days Days3841 93.0%  
Net fixed assets Rs m1,40612,610 11.2%   
Share capital Rs m166239 69.4%   
"Free" reserves Rs m6,28634,490 18.2%   
Net worth Rs m6,45535,027 18.4%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m8,82854,387 16.2%  
Interest coverage xNM13.6-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.9 129.6%   
Return on assets %8.613.6 63.2%  
Return on equity %11.819.2 61.2%  
Return on capital %17.124.9 68.7%  
Exports to sales %8.312.9 64.0%   
Imports to sales %21.03.1 681.9%   
Exports (fob) Rs m8696,461 13.5%   
Imports (cif) Rs m2,2091,540 143.4%   
Fx inflow Rs m9596,563 14.6%   
Fx outflow Rs m2,6123,012 86.7%   
Net fx Rs m-1,6533,552 -46.5%   
CASH FLOW
From Operations Rs m1,0707,259 14.7%  
From Investments Rs m-7501,864 -40.2%  
From Financial Activity Rs m-150-9,273 1.6%  
Net Cashflow Rs m171-150 -113.9%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 33.1 55.0%  
FIIs % 1.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 0.0 -  
Shareholders   28,591 68,381 41.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  PFIZER  ALEMBIC PHARMA  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 22, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - FULFORD INDIA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS